Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients

CIKRIKCIOGLU, M.; OZDEMIR, A.; SEKIN, Y.; YALCIN, BURAK; ALTAY, M.; GUNDOGDU, A.; Erkal, S.; Kazancioglu, Rümeyza; ERKOC, R.

Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients

Atıf İçin Kopyala

CIKRIKCIOGLU M. A. , OZDEMIR A. A. , SEKIN Y., YALCIN B. , ALTAY M., GUNDOGDU A., et al.

MINERVA UROLOGICA E NEFROLOGICA, cilt.67, ss.187-196, 2015 (SCI İndekslerine Giren Dergi)

Cilt numarası: 67 Konu: 3
Basım Tarihi: 2015
Dergi Adı: MINERVA UROLOGICA E NEFROLOGICA
Sayfa Sayısı: ss.187-196

Özet

Aim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.